EPISODE · Mar 15, 2022 · 34 MIN
Episode 7: Exploring the Faricimab Trials
from Talking Euretina · host Whipsmart Media
In January, The Lancet journal published studies showing that across 4 trials, faricimab improved and maintained vision in two leading causes of vision loss and reduced time between treatments. In this episode, we examine the results and implications of the research in an expert discussion chaired by Prof Anat Loewenstein (Tel Aviv Medical Centre) and Prof Reinier Schlingemann (Amsterdam University and Jules Gonin). They are joined by Ramin Tadayoni (Paris University), Professor Sandrine Zweifel (University Hospital Zurich) and Professor Usha Chakravarthy (Queen's University Belfast)
What this episode covers
In January, The Lancet journal published studies showing that across 4 trials, faricimab improved and maintained vision in two leading causes of vision loss and reduced time between treatments. In this episode, we examine the results and implications of the research in an expert discussion chaired by Prof Anat Loewenstein (Tel Aviv Medical Centre) and Prof Reinier Schlingemann (Amsterdam University and Jules Gonin). They are joined by Ramin Tadayoni (Paris University), Professor Sandrine Zweifel (University Hospital Zurich) and Professor Usha Chakravarthy (Queen's University Belfast)
NOW PLAYING
Episode 7: Exploring the Faricimab Trials
No transcript for this episode yet
Similar Episodes
Jun 9, 2026 ·50m
Jun 1, 2026 ·31m
May 25, 2026 ·39m
May 17, 2026 ·37m
May 8, 2026 ·39m
Apr 28, 2026 ·25m